Agriculture›
Apparel and fashion accessories›
Construction & real estate›💡Electronic & Electrical›🍎Food & Beverages›🛋️Home furnishing & supplies›⚗️Industrial goods & chemical›🪨Minerals & metals›📦Miscellaneous›
Agriculture›
Apparel and fashion accessories›
Construction & real estate›💡Electronic & Electrical›🍎Food & Beverages›🛋️Home furnishing & supplies›⚗️Industrial goods & chemical›🪨Minerals & metals›📦Miscellaneous›

MASTOCHECK is a quantitative in vitro diagnostic kit designed for early breast cancer screening through the detection of specific protein biomarkers in blood serum or plasma. Developed using a patented algorithm, it analyzes three protein biomarkers closely associated with early-stage breast cancer, delivering a reported accuracy of 92% based on validation studies.
The kit includes diagnostic reagents such as protein biomarkers, antibodies, ELISA substrate solution, calibrator controls, and wash buffer. It is classified as a Class II/III medical device, requiring cold-chain logistics for storage and transport. The product is compatible with standard ELISA instrumentation, enabling integration into high-throughput clinical pathology laboratories and oncology departments.
Hospitals and screening institutions in South Korea have adopted MASTOCHECK, with over 400 facilities using the test as of 2023. Developed under the leadership of Professor Dong-Young Noh of Seoul National University, the kit underwent extensive validation, including analysis of approximately 600,000 proteins, before receiving MFDS approval in January 2019. Buyers should confirm regulatory status for import and local certification requirements.
| Test Type | Quantitative In Vitro Diagnostic |
| Sample Type | Blood Serum or Plasma |
| Target Biomarkers | 3 Protein Biomarkers |
| Reported Accuracy | 92% (based on patented algorithm) |
| Device Classification | Class II/III Medical Device |
| Assay Method | ELISA (Enzyme-Linked Immunosorbent Assay) |
| Kit Components | Protein Biomarkers, Antibodies, ELISA Substrate Solution, Calibrator Controls, Wash Buffer |
| Storage Requirement | Cold-Chain Logistics |
| Instrument Compatibility | Standard ELISA Instrumentation |
| Regulatory Approval | MFDS (South Korea, January 2019) |
Bertis Inc. is headquartered in Gwacheon-Si, Gyeonggi-Do, South Korea, with its office located at 3rd Floor, B Building, 33 Gwacheon-daero 7-gil. The company specializes in the development and commercialization of diagnostic reagents, with a focus on early cancer detection technologies.
The supplier holds a harbor trust tier but does not list a response rate or average response time. Bertis Inc. developed MASTOCHECK in collaboration with Seoul National University, leveraging research led by Professor Dong-Young Noh, a recognized authority in breast cancer diagnostics. Buyers should directly confirm the company’s production capacity, export capabilities, and compliance with international diagnostic standards.
MastoCheck is a quantitative in vitro diagnostic kit designed for early breast cancer screening through detection of specific protein biomarkers in blood serum or plasma samples. Suitable for clinical pathology laboratories, oncology departments, and hospital diagnostic centers, this kit supports high-throughput screening workflows with standard ELISA instrumentation. As a regulated Class II/III medical device, it requires proper cold-chain logistics and is classified under standard diagnostic reagent HS codes for international trade clearance.
| Business Type | Supplier |
| Year Established | Recently Joined |
| Employees | Contact Supplier |
| Annual Revenue | Contact Supplier |
| Main Products | View Products Tab |
| Major Markets | Global |
| Response Time | Contact Supplier |
| Response Rate | New Supplier |
Before importing MASTOCHECK from Bertis Inc., verify the product’s MFDS approval and request documentation confirming compliance with international diagnostic standards, such as ISO 13485 for medical devices. Ensure the supplier provides certificates of analysis (CoA) and stability data for each batch, as these are critical for regulatory clearance in your market.
Cold-chain logistics are essential for this product, so confirm the supplier’s ability to maintain temperature-controlled conditions during transport from South Korea. Discuss Incoterms such as CIP or DDP to clarify responsibility for shipping, insurance, and customs clearance. Payment terms should be negotiated in advance, with options like L/C or T/T tied to shipment milestones.
Upon receipt, inspect the kit for intact packaging and proper temperature indicators to ensure the reagents have not been compromised. Conduct a pilot test to validate performance with your laboratory’s ELISA instrumentation. Maintain records of all documentation, including import permits, to demonstrate compliance with local regulatory requirements for diagnostic devices.
Active buying requirements from importers looking for Similar products
Compare alternatives, find similar products and connect with verified suppliers
When sourcing Mastocheck Breast Cancer Early Diagnosis for your business, securing the right balance of quality and cost is essential. Bertis Inc., a verified supplier based in South Korea (Republic Of Korea), offers this product with key specifications including Quantitative ELISA Diagnostic Kit for Breast Cancer Screening, 3 Protein Tumor Markers (CA 15-3, CEA, and Additional Breast Cancer Associated Proteins), and Serum or Plasma (venous blood). By purchasing directly from the manufacturer or authorized exporter, buyers can negotiate favorable FOB prices starting at $8035096./Unit and manage bulk orders with a minimum order quantity (MOQ) of 1 Unit. This product is actively traded under HS Code 3822.90, making it a staple in the Diagnostic Kits sector with strong demand from importing countries worldwide.
Importing Mastocheck Breast Cancer requires careful attention to shipping logistics, customs compliance, and secure payment terms. Bertis Inc. offers flexible shipping options such as Full Container Load (FCL) or Less than Container Load (LCL) via sea freight. To ensure a smooth transaction, buyers should verify import duties for HS Code 3822.90 in their destination country. Common payment methods for international B2B transactions include Letter of Credit (L/C), Telegraphic Transfer (T/T), and Documents against Payment (D/P). All transactions and RFQs are facilitated through EximNext, a leading import export marketplace designed to make cross-border trade secure and efficient.
Finding trustworthy partners is the foundation of successful importing. The supplier of this Mastocheck Breast Cancer has been verified on our platform. Whether you are a distributor, wholesaler, or procurement manager, you can request a free quotation, ask for product samples, and finalize your bulk purchase with confidence. EximNext hosts thousands of verified manufacturers and exporters across 200+ countries. Explore similar products in the Diagnostic Kits category and connect with top-tier exporters on our comprehensive online B2B marketplace. Start your sourcing journey today.
Importing Mastocheck Breast Cancer requires careful attention to shipping logistics, customs compliance, and secure payment terms. Common shipping options include Full Container Load (FCL) or Less than Container Load (LCL) via sea freight. Buyers should verify import duties for HS Code 3822.90 in their destination country. Common payment methods include Letter of Credit (L/C), Telegraphic Transfer (T/T), and Documents against Payment (D/P).
The current listed wholesale price for Mastocheck Breast Cancer Early Diagnosis from Bertis Inc. is $8035096./Unit on FOB terms from South Korea (Republic Of Korea). Prices may vary depending on order volume, packaging, and destination. For the most accurate bulk quote, send a direct RFQ to Bertis Inc. through EximNext.
The supplier, Bertis Inc., has set a Minimum Order Quantity (MOQ) of 1 Unit for Mastocheck Breast Cancer. For sample requests or smaller trial orders, contact the supplier directly through our platform's inquiry system.
For international shipping and customs clearance, Mastocheck Breast Cancer Early Diagnosis is classified under HS Code 3822.90. Buyers should verify their local customs regulations to determine applicable import duties and taxes for this classification.
To import Mastocheck Breast Cancer from South Korea (Republic Of Korea), negotiate shipping terms (FOB, CIF, or EXW) directly with Bertis Inc.. Ensure you have the necessary import licenses for Diagnostic Kits products in your destination country.
Yes, Bertis Inc. is a verified supplier on EximNext. You can view their complete company profile, business registration details, certifications, and export history before placing a bulk order.
The key specifications for Mastocheck Breast Cancer Early Diagnosis supplied by Bertis Inc. include Quantitative ELISA Diagnostic Kit for Breast Cancer Screening, 3 Protein Tumor Markers (CA 15-3, CEA, and Additional Breast Cancer Associated Proteins), and Serum or Plasma (venous blood). For a complete technical data sheet or Certificate of Analysis (COA), send an inquiry directly to the supplier through EximNext.
Bertis Inc. offers Mastocheck Breast Cancer with standard export packaging. Custom packaging, private labeling, and OEM/ODM options may also be available for large wholesale orders.
Mastocheck Breast Cancer is actively imported by buyers worldwide. Request a destination-specific CIF or CFR quote from Bertis Inc. through our platform.
Bertis Inc. maintains international quality certifications. These ensure that the Mastocheck Breast Cancer meets international quality, safety, and regulatory standards required for cross-border trade.
Click "Request Quotation" on this product page, specify your required quantity, preferred shipping terms, and destination country. Bertis Inc. will respond with a detailed wholesale quote including FOB pricing, lead time, and payment options.
Common payment methods include Letter of Credit (L/C), Telegraphic Transfer (T/T), Documents against Payment (D/P), and Escrow services. Confirm accepted terms directly with Bertis Inc..
Discover more products in Diagnostic Kits from verified suppliers worldwide.